223 related articles for article (PubMed ID: 9430698)
1. Cell lines from kidney proximal tubules of a patient with Lowe syndrome lack OCRL inositol polyphosphate 5-phosphatase and accumulate phosphatidylinositol 4,5-bisphosphate.
Zhang X; Hartz PA; Philip E; Racusen LC; Majerus PW
J Biol Chem; 1998 Jan; 273(3):1574-82. PubMed ID: 9430698
[TBL] [Abstract][Full Text] [Related]
2. The protein deficient in Lowe syndrome is a phosphatidylinositol-4,5-bisphosphate 5-phosphatase.
Zhang X; Jefferson AB; Auethavekiat V; Majerus PW
Proc Natl Acad Sci U S A; 1995 May; 92(11):4853-6. PubMed ID: 7761412
[TBL] [Abstract][Full Text] [Related]
3. OCRL deficiency impairs endolysosomal function in a humanized mouse model for Lowe syndrome and Dent disease.
Festa BP; Berquez M; Gassama A; Amrein I; Ismail HM; Samardzija M; Staiano L; Luciani A; Grimm C; Nussbaum RL; De Matteis MA; Dorchies OM; Scapozza L; Wolfer DP; Devuyst O
Hum Mol Genet; 2019 Jun; 28(12):1931-1946. PubMed ID: 30590522
[TBL] [Abstract][Full Text] [Related]
4. Lowe syndrome, a deficiency of phosphatidylinositol 4,5-bisphosphate 5-phosphatase in the Golgi apparatus.
Suchy SF; Olivos-Glander IM; Nussabaum RL
Hum Mol Genet; 1995 Dec; 4(12):2245-50. PubMed ID: 8634694
[TBL] [Abstract][Full Text] [Related]
5. The diversity and possible functions of the inositol polyphosphate 5-phosphatases.
Erneux C; Govaerts C; Communi D; Pesesse X
Biochim Biophys Acta; 1998 Dec; 1436(1-2):185-99. PubMed ID: 9838104
[TBL] [Abstract][Full Text] [Related]
6. Oculocerebrorenal syndrome of Lowe (OCRL) controls leukemic T-cell survival by preventing excessive PI(4,5)P
Chen H; Lu C; Tan Y; Weber-Boyvat M; Zheng J; Xu M; Xiao J; Liu S; Tang Z; Lai C; Li M; Olkkonen VM; Yan D; Zhong W
J Biol Chem; 2023 Jun; 299(6):104812. PubMed ID: 37172724
[TBL] [Abstract][Full Text] [Related]
7. Loss of OCRL increases ciliary PI(4,5)P
Prosseda PP; Luo N; Wang B; Alvarado JA; Hu Y; Sun Y
J Cell Sci; 2017 Oct; 130(20):3447-3454. PubMed ID: 28871046
[TBL] [Abstract][Full Text] [Related]
8. Species-specific difference in expression and splice-site choice in Inpp5b, an inositol polyphosphate 5-phosphatase paralogous to the enzyme deficient in Lowe Syndrome.
Bothwell SP; Farber LW; Hoagland A; Nussbaum RL
Mamm Genome; 2010 Oct; 21(9-10):458-66. PubMed ID: 20872266
[TBL] [Abstract][Full Text] [Related]
9. Kidney Tubular Ablation of
Inoue K; Balkin DM; Liu L; Nandez R; Wu Y; Tian X; Wang T; Nussbaum R; De Camilli P; Ishibe S
J Am Soc Nephrol; 2017 May; 28(5):1399-1407. PubMed ID: 27895154
[TBL] [Abstract][Full Text] [Related]
10. Phosphoinositide phosphatases: just as important as the kinases.
Dyson JM; Fedele CG; Davies EM; Becanovic J; Mitchell CA
Subcell Biochem; 2012; 58():215-79. PubMed ID: 22403078
[TBL] [Abstract][Full Text] [Related]
11. Phosphatidylinositol signalling reactions.
Zhang X; Majerus PW
Semin Cell Dev Biol; 1998 Apr; 9(2):153-60. PubMed ID: 9599410
[TBL] [Abstract][Full Text] [Related]
12. Complete oculocerebrorenal phenotype of Lowe syndrome in a female patient with half reduction of inositol polyphosphate 5-phosphatase.
Yamamoto K; Hasegawa Y; Ohata Y; Satomura K; Mizoguchi Y; Shimotsuji T; Yamamoto T
CEN Case Rep; 2020 May; 9(2):95-100. PubMed ID: 31707643
[TBL] [Abstract][Full Text] [Related]
13. A novel OCRL1 mutation in a patient with the mild phenotype of Lowe syndrome.
Sugimoto K; Nishi H; Miyazawa T; Fujita S; Okada M; Takemura T
Tohoku J Exp Med; 2014 Mar; 232(3):163-6. PubMed ID: 24614960
[TBL] [Abstract][Full Text] [Related]
14. The 5-phosphatase OCRL in Lowe syndrome and Dent disease 2.
De Matteis MA; Staiano L; Emma F; Devuyst O
Nat Rev Nephrol; 2017 Aug; 13(8):455-470. PubMed ID: 28669993
[TBL] [Abstract][Full Text] [Related]
15. OCRL controls trafficking through early endosomes via PtdIns4,5P₂-dependent regulation of endosomal actin.
Vicinanza M; Di Campli A; Polishchuk E; Santoro M; Di Tullio G; Godi A; Levtchenko E; De Leo MG; Polishchuk R; Sandoval L; Marzolo MP; De Matteis MA
EMBO J; 2011 Oct; 30(24):4970-85. PubMed ID: 21971085
[TBL] [Abstract][Full Text] [Related]
16. Effects of Proximal Tubule Shortening on Protein Excretion in a Lowe Syndrome Model.
Gliozzi ML; Espiritu EB; Shipman KE; Rbaibi Y; Long KR; Roy N; Duncan AW; Lazzara MJ; Hukriede NA; Baty CJ; Weisz OA
J Am Soc Nephrol; 2020 Jan; 31(1):67-83. PubMed ID: 31676724
[TBL] [Abstract][Full Text] [Related]
17. The inositol polyphosphate 5-phosphatases: traffic controllers, waistline watchers and tumour suppressors?
Astle MV; Horan KA; Ooms LM; Mitchell CA
Biochem Soc Symp; 2007; (74):161-81. PubMed ID: 17233589
[TBL] [Abstract][Full Text] [Related]
18. Increased levels of plasma lysosomal enzymes in patients with Lowe syndrome.
Ungewickell AJ; Majerus PW
Proc Natl Acad Sci U S A; 1999 Nov; 96(23):13342-4. PubMed ID: 10557322
[TBL] [Abstract][Full Text] [Related]
19. Structure and function of the Lowe syndrome protein OCRL1.
Lowe M
Traffic; 2005 Sep; 6(9):711-9. PubMed ID: 16101675
[TBL] [Abstract][Full Text] [Related]
20. Suppression of intestinal calcium entry channel TRPV6 by OCRL, a lipid phosphatase associated with Lowe syndrome and Dent disease.
Wu G; Zhang W; Na T; Jing H; Wu H; Peng JB
Am J Physiol Cell Physiol; 2012 May; 302(10):C1479-91. PubMed ID: 22378746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
